CINGULATE THERAPEUTICS Trademark

Trademark Overview


On Monday, April 16, 2018, a trademark application was filed for CINGULATE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CINGULATE THERAPEUTICS trademark a serial number of 87878041. The federal status of this trademark filing is REGISTERED as of Tuesday, September 8, 2020. This trademark is owned by Cingulate Therapeutics LLC. The CINGULATE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder (ADHD); conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention- deficit/hyperactivity disorder (ADHD)
cingulate therapeutics

General Information


Serial Number87878041
Word MarkCINGULATE THERAPEUTICS
Filing DateMonday, April 16, 2018
Status700 - REGISTERED
Status DateTuesday, September 8, 2020
Registration Number6144564
Registration DateTuesday, September 8, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder (ADHD); conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention- deficit/hyperactivity disorder (ADHD)

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 23, 2018
Primary Code042
First Use Anywhere DateSunday, June 1, 2014
First Use In Commerce DateSunday, June 1, 2014

Trademark Owner History


Party NameCingulate Therapeutics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressKansas City, KS 66205

Party NameCingulate Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKansas City, KS 66205

Party NameCingulate Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKansas City, KS 66205

Trademark Events


Event DateEvent Description
Thursday, April 19, 2018NEW APPLICATION ENTERED
Monday, April 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 4, 2018ASSIGNED TO EXAMINER
Monday, August 13, 2018NON-FINAL ACTION WRITTEN
Friday, December 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 13, 2018NON-FINAL ACTION E-MAILED
Monday, August 13, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 7, 2019SUSPENSION LETTER WRITTEN
Thursday, August 8, 2019ASSIGNED TO LIE
Thursday, May 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 8, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 12, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, January 7, 2019LETTER OF SUSPENSION E-MAILED
Monday, January 7, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 21, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED